2023
1. Different Routes for the Construction of Biologically Active Diversely Functionalized Bicyclo[3.3.1]Nonanes: An Exploration of New Perspectives for Anticancer Chemotherapeutics.
Roy, N.; Das, R.; Paira, R.; Paira, P.
RSC Advances. Royal Society of Chemistry July 25, 2023, pp 22389–22480.
​
​
​
​
​
​
​
2. Synthesis, Characterisation, Photophysical and Electrochemical Properties, and Biomolecular Interaction of 2,2′-Biquinoline-Based Phototoxic Ru(II)/Ir(II) Complexes.
Das, U.; Paira, P.
Dalton Transactions 2023, 52 (36), 12608–12617.
​
​
​
​
​
​
​​3. GSH Resistant, Luminescent 2-(Pyren-1-Yl)-1H-Imidazo[4,5-f][1,10]Phenanthroline-Based Ru(II)/Ir(III)/Re(I) Complexes for Phototoxicity in Triple-Negative Breast Cancer Cells.
Das, R.; Paira, P.
Dalton Transactions 2023, 52 (42), 15365–15376.
​
​
​
​
​
​
​
4. Recent Advances on Organelle Specific Ru(II)/Ir(III)/Re(I) Based Complexes for Photodynamic Therapy.
Kar, B.; Das, U.; Roy, N.; Paira, P.
Coord Chem Rev 2023, 474, 214860.
​
​
​
​
​
​
​
5. Luminescent 11-{Naphthalen-1-Yl}dipyrido[3,2-a:2′,3′-c]Phenazine-Based Ru(II)/Ir(III)/Re(I) Complexes for HCT-116 Colorectal Cancer Stem Cell Therapy.
Das, U.; Shanavas, S.; Nagendra, A. H.; Kar, B.; Roy, N.; Vardhan, S.; Sahoo, S. K.; Panda, D.; Bose, B.; Paira, P.
ACS Appl Bio Mater 2023, 6 (2), 410–424.
​
​
​
​
​
​
​
6. G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2′-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells.
Roy, N.; Shanavas, S.; Kar, B.; Thilak Babu, L.; Das, U.; Vardhan, S.; Sahoo, S. K.; Bose, B.; Rajagopalan, V.; Paira, P.
ACS Omega 2023, 8 (13), 12283–12297.
​
​
​
​
​
​
​
7. CuAAC “Click”-Derived Luminescent 2-(2-(4-(4-(Pyridin-2-Yl)-1H-1,2,3-Triazol-1-Yl)Butoxy)Phenyl)Benzo[d]Thiazole-Based Ru(II)/Ir(III)/Re(I) Complexes as Anticancer Agents.
Thilak Babu, L.; Paira, P.
ACS Omega 2023, 8 (36), 32382–32395.
